1. Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment 
Richard Fleming, Ph.D., Lyndal Harborne, B.Med., David T. MacLaughlin, Ph.D., Daniel Ling, Jane Norman, M.D., Naveed Sattar, M.R.C.Path., David B. Seifer, M.D. 
Fertility and Sterility 
Volume 83, Issue 1, Pages (January 2005)
DOI: /j.fertnstert
Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions

2. FIGURE 1
The changes in the mean concentrations of A and MIS during metformin treatment of women with PCOS. The significance values refer to changes between the start of treatment (T0) and at 4 months as well as between the 4- and 8-month intervals.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions